|
Volumn 2, Issue 1, 2001, Pages 33-
|
Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2;
ARTICLE;
GENE THERAPY;
GENETICS;
HUMAN;
MALE;
PHASE 1 CLINICAL TRIAL;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
GENE THERAPY;
HUMANS;
INTERLEUKIN-2;
MALE;
PROSTATIC NEOPLASMS;
|
EID: 0035248115
PISSN: 15272737
EISSN: None
Source Type: Journal
DOI: 10.1007/s11934-001-0019-7 Document Type: Article |
Times cited : (9)
|
References (0)
|